Percutaneous Coronary Interventions
Summary
Coronary stents, which include bare metal stents, drug-eluting stents (DESes), covered stents, and bioabsorbable stents (BASes). De novo stenosis, acute myocardial infarction (AMI), bifurcation lesions, small vessel disease (SVD), saphenous vein grafts (SVGs), left main coronary artery disease (LMCAD), and chronic total occlusions (CTOs). In the US and 5EU, coronary stents market value is expected to decline slowly, whereas it is expected to demonstrate steady growth in the APAC and South American regions
Newer technologies, such as BASes and the third generation of DESes aim to address unmet needs of complex lesions and challenging populations. The development and commercialization of the next generation of DESes with innovative platforms indicates the continued value of DESes in the coronary market. The coronary stents market is largely dominated by a few key players, including Abbott Vascular, Medtronic, and Boston Scientific. Other key players include B. Braun, Biosensors International, Biotronik, and Terumo as they develop innovative coronary stent platforms.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/839751-medipoint-percutaneous-coronary-interventions-global-analysis-and-market-forecasts
Scope of the Report
- Overview of percutaneous coronary interventions, including reimbursement trends and M&A analysis
- Annualized total market revenue by type of device, procedure trends, and market outlooks by country through 2022.
- Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies on the market.
- Pipeline analysis: Comprehensive data split across different stages of development and analysis of emerging trends in design.
Key Players
Aachen Resonance, Abbott Vascular, Alvimedica, amg International, B. Braun, Balton , Biosensors International, Biotronik, Blue Medical, Boston Specific, Cardionovum, Concept Medical, Disa Vascular, Elixir Medical, Eucatech, Eurocor, Hexacath, InSitu Technologies, Iramed, ITGI Medical, JW Medical Systems, Kyoto Medical Planning, Lepu Medical Technology, Medinol, Medtronic ,Meril Life Sciences, Micell Technologies, MicroPort, Minvasys, MIV Therapeutics, OrbusNeich, Relisys , Rontis Medical, Sahajanand Medical Technologies, Stentys, Svelte Medical Systems, Terumo, Translumina, Tryton Medical, Vascular Concepts
Table of Contents
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 11
2.1 Catalyst 11
2.2 Related Reports 12
3 Market Access 13
3.1 Reimbursement Trends 13
3.1.1 North America 13
3.1.2 Europe 16
3.1.3 Asia-Pacific 17
3.1.4 South America 20
3.1.5 Middle East and Africa 21
3.2 Mergers and Acquisitions/Key Partnerships 23
4 Unmet Needs and Market Opportunity Analysis 24
4.1 Improving Clinical Outcomes in Complex Coronary Indications 24
4.1.1 Bifurcation Lesions 25
4.1.2 Chronic Total Occlusions 26
4.1.3 Heavily Calcified Lesions 27
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/839751-medipoint-percutaneous-coronary-interventions-global-analysis-and-market-forecasts
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Summary
Coronary stents, which include bare metal stents, drug-eluting stents (DESes), covered stents, and bioabsorbable stents (BASes). De novo stenosis, acute myocardial infarction (AMI), bifurcation lesions, small vessel disease (SVD), saphenous vein grafts (SVGs), left main coronary artery disease (LMCAD), and chronic total occlusions (CTOs). In the US and 5EU, coronary stents market value is expected to decline slowly, whereas it is expected to demonstrate steady growth in the APAC and South American regions
Newer technologies, such as BASes and the third generation of DESes aim to address unmet needs of complex lesions and challenging populations. The development and commercialization of the next generation of DESes with innovative platforms indicates the continued value of DESes in the coronary market. The coronary stents market is largely dominated by a few key players, including Abbott Vascular, Medtronic, and Boston Scientific. Other key players include B. Braun, Biosensors International, Biotronik, and Terumo as they develop innovative coronary stent platforms.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/839751-medipoint-percutaneous-coronary-interventions-global-analysis-and-market-forecasts
Scope of the Report
- Overview of percutaneous coronary interventions, including reimbursement trends and M&A analysis
- Annualized total market revenue by type of device, procedure trends, and market outlooks by country through 2022.
- Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the emerging technologies on the market.
- Pipeline analysis: Comprehensive data split across different stages of development and analysis of emerging trends in design.
Key Players
Aachen Resonance, Abbott Vascular, Alvimedica, amg International, B. Braun, Balton , Biosensors International, Biotronik, Blue Medical, Boston Specific, Cardionovum, Concept Medical, Disa Vascular, Elixir Medical, Eucatech, Eurocor, Hexacath, InSitu Technologies, Iramed, ITGI Medical, JW Medical Systems, Kyoto Medical Planning, Lepu Medical Technology, Medinol, Medtronic ,Meril Life Sciences, Micell Technologies, MicroPort, Minvasys, MIV Therapeutics, OrbusNeich, Relisys , Rontis Medical, Sahajanand Medical Technologies, Stentys, Svelte Medical Systems, Terumo, Translumina, Tryton Medical, Vascular Concepts
Table of Contents
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 11
2.1 Catalyst 11
2.2 Related Reports 12
3 Market Access 13
3.1 Reimbursement Trends 13
3.1.1 North America 13
3.1.2 Europe 16
3.1.3 Asia-Pacific 17
3.1.4 South America 20
3.1.5 Middle East and Africa 21
3.2 Mergers and Acquisitions/Key Partnerships 23
4 Unmet Needs and Market Opportunity Analysis 24
4.1 Improving Clinical Outcomes in Complex Coronary Indications 24
4.1.1 Bifurcation Lesions 25
4.1.2 Chronic Total Occlusions 26
4.1.3 Heavily Calcified Lesions 27
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/839751-medipoint-percutaneous-coronary-interventions-global-analysis-and-market-forecasts
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
